PubMed

Are the adverse effects of glitazones linked to induced testosterone deficiency?

Carruthers M, Trinick TR, Jankowska E, Traish AM.

Cardiovasc Diabetol. 2008 Oct 15;7:30. Review.PMID: 18922158 [PubMed - indexed for MEDLINE]Related articlesFree article

The role of glitazones in management of type 2 diabetes. A dream or a nightmare?

Lindberg M, Astrup A.

Obes Rev. 2007 Sep;8(5):381-4.PMID: 17716295 [PubMed - indexed for MEDLINE]Related articles

Combined thiazolidinedione-insulin therapy: should we be concerned about safety?

Scheen AJ.

Drug Saf. 2004;27(12):841-56. Review.PMID: 15366973 [PubMed - indexed for MEDLINE]Related articles

The paradox dividing testosterone deficiency symptoms and androgen assays: a closer look at the cellular and molecular mechanisms of androgen action.

Carruthers M.

J Sex Med. 2008 Apr;5(4):998-1012. Epub 2008 Jan 21. Review.PMID: 18221290 [PubMed - indexed for MEDLINE]Related articles

[Glitazones and congestive heart failure: update on PROactive, ADOPT, DREAM and RECORD clinical trials]

De Flines J, Scheen AJ.

Rev Med Suisse. 2007 Aug 29;3(122):1876, 1878-83. Review. French. PMID: 17896661 [PubMed - indexed for MEDLINE]Related articles

Type 2 diabetes, thiazolidinediones, and cardiovascular risk.

Taylor C, Hobbs FD.

Br J Gen Pract. 2009 Jul;59(564):520-4.PMID: 19567003 [PubMed - indexed for MEDLINE]Related articles

[Heart failure with thiazolidinedione treatment: what do we know today?]

Erdmann E.

Dtsch Med Wochenschr. 2009 Jan;134(4):154-8. Epub 2009 Jan 15. Review. German. PMID: 19148858 [PubMed - indexed for MEDLINE]Related articles

[Heart, diabetes and glitazones]

Le Feuvre C.

Ann Endocrinol (Paris). 2004 Feb;65(1 Suppl):S26-35. Review. French. PMID: 15163921 [PubMed - indexed for MEDLINE]Related articles

Glitazones in type 2 diabetes: an update.

[No authors listed]

Drug Ther Bull. 2008 Apr;46(4):25-9. Review.PMID: 18403615 [PubMed - indexed for MEDLINE]Related articles

[Cardiovascular effects of rosiglitazone]

Le Feuvre C.

Presse Med. 2004 Jun 19;33(11):735-45. Review. French. PMID: 15257231 [PubMed - indexed for MEDLINE]Related articles

Thiazolidinediones and their fluid-related adverse effects: facts, fiction and putative management strategies.

Karalliedde J, Buckingham RE.

Drug Saf. 2007;30(9):741-53. Review.PMID: 17722967 [PubMed - indexed for MEDLINE]Related articles

Risk of fractures with glitazones: a critical review of the evidence to date.

Bodmer M, Meier C, Kraenzlin ME, Meier CR.

Drug Saf. 2009;32(7):539-47. doi: 10.2165/00002018-200932070-00001. Review.PMID: 19530741 [PubMed - indexed for MEDLINE]Related articles

Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency.

Boyanov MA, Boneva Z, Christov VG.

Aging Male. 2003 Mar;6(1):1-7.PMID: 12809074 [PubMed - indexed for MEDLINE]Related articles

The dark side of testosterone deficiency: III. Cardiovascular disease.

Traish AM, Saad F, Feeley RJ, Guay A.

J Androl. 2009 Sep-Oct;30(5):477-94. Epub 2009 Apr 2. Review.PMID: 19342698 [PubMed - indexed for MEDLINE]Related articles

Thiazolidinediones, peripheral oedema and congestive heart failure: what is the evidence?

Patel C, Wyne KL, McGuire DK.

Diab Vasc Dis Res. 2005 May;2(2):61-6. Review.PMID: 16305060 [PubMed - indexed for MEDLINE]Related articles

The effects of metformin on endogenous androgens and SHBG in women: a systematic review and meta-analysis.

Barba M, Schünemann HJ, Sperati F, Akl EA, Musicco F, Guyatt G, Muti P.

Clin Endocrinol (Oxf). 2009 May;70(5):661-70. Epub 2008 Oct 21.PMID: 19178532 [PubMed - indexed for MEDLINE]Related articles

Thiazolidinediones: effects on the development and progression of type 2 diabetes and associated vascular complications.

Krentz A.

Diabetes Metab Res Rev. 2009 Feb;25(2):112-26. Review.PMID: 19219860 [PubMed - indexed for MEDLINE]Related articles

Thiazolidinediones and cardiovascular events in patients with type 2 diabetes mellitus: a retrospective cohort study of over 473,000 patients using the National Health Insurance database in Taiwan.

Hsiao FY, Huang WF, Wen YW, Chen PF, Kuo KN, Tsai YW.

Drug Saf. 2009;32(8):675-90. doi: 10.2165/00002018-200932080-00006.PMID: 19591532 [PubMed - indexed for MEDLINE]Related articles

Cardiovascular risk of rosiglitazone: another perspective.

Waksman JC.

J Pharm Pharmacol. 2008 Dec;60(12):1573-82. Review.PMID: 19000361 [PubMed - indexed for MEDLINE]Related articles

Safety and tolerability of pioglitazone in high-risk patients with type 2 diabetes: an overview of data from PROactive.

Dormandy J, Bhattacharya M, van Troostenburg de Bruyn AR; PROactive investigators.

Drug Saf. 2009;32(3):187-202. doi: 10.2165/00002018-200932030-00002. Review.PMID: 19338377 [PubMed - indexed for MEDLINE]Related articles